Leo Pharma
Clinical trials sponsored by Leo Pharma, explained in plain language.
-
New cream shows promise for painful hand and foot pustules
Disease control Recruiting nowThis study tests a cream called delgocitinib for people with mild to severe palmoplantar pustulosis, a skin condition causing painful pus-filled blisters on hands and feet. About 135 adults will apply the cream twice daily for 16 weeks. The main goal is to see if the cream reduce…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New shot could tame severe eczema in kids as young as 6 months
Disease control Recruiting nowThis study tests whether a drug called tralokinumab, given as a shot along with steroid cream, can safely control moderate-to-severe eczema in children aged 6 months to under 12 years. About 195 participants will receive either the drug or a placebo for 16 weeks, then all will ge…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New cream could ease painful skin condition lichen sclerosus
Disease control Recruiting nowThis study tests a cream called delgocitinib for lichen sclerosus, a skin condition that causes itching, pain, and scarring in the genital area. About 652 adults with mild to severe disease will apply the cream twice daily for up to 52 weeks. Researchers will check if the cream i…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC